Mercer Global Advisors
EDIT icon

Mercer Global Advisors’s Editas Medicine EDIT Stock Holding History

Mercer Global Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
37,644
+11,862
+46% +$34.7K ﹤0.01% 3382
2026
Q1 		$63.7K Buy
+25,782
New +$54.6K ﹤0.01% 3101
2023
Q4 		– Sell
-23,576
Closed -$184K – 2026
2023
Q3 		$184K Buy
23,576
+3,346
+17% +$28.7K ﹤0.01% 1779
2023
Q2 		$166K Buy
20,230
+4,591
+29% +$40K ﹤0.01% 1763
2023
Q1 		$113K Buy
+15,639
New +$139K ﹤0.01% 1819
2021
Q1 		– Sell
-3,644
Closed -$255K – 1637
2020
Q4 		$255K Buy
+3,644
New +$150K ﹤0.01% 1133
2020
Q1 		– Sell
-6,784
Closed -$201K – 1141
2019
Q4 		$201K Buy
+6,784
New +$169K ﹤0.01% 1083

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mercer Global Advisors's EDIT Position: Q2 2026 in Review

Mercer Global Advisors increased its Editas Medicine (EDIT) stake by 46% in Q2 2026, buying an estimated $34.7K and bringing the position to 37,644 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #3382.

Mercer Global Advisors first reported a position in EDIT in Q4 2019 and has held it in 7 quarters since. The position peaked at $255K in Q4 2020. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Mercer Global Advisors held 37,644 shares of Editas Medicine worth $122K as of Q2 2026.
  • Mercer Global Advisors bought 11,862 Editas Medicine shares in Q2 2026, an estimated $34.7K.
  • Editas Medicine made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3382 holding.
  • Mercer Global Advisors first reported a position in Editas Medicine in Q4 2019 and has held it in 7 quarters since.
  • Mercer Global Advisors's Editas Medicine position peaked at $255K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.